BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 19226331)

  • 1. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
    Ikeda K; Kobayashi M; Someya T; Saitoh S; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
    J Viral Hepat; 2009 Jun; 16(6):437-43. PubMed ID: 19226331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
    Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
    Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
    J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F; Tramuto F; Orlando A; Vizzini G; Meli V; Cerame G; Mazzucco W; Virdone R; Palazzo U; Villafrate MR; Tagger A; Romano N
    J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
    Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
    J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
    Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
    Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase.
    Ikeda K; Arase Y; Saitoh S; Kobayashi M; Someya T; Hosaka T; Sezaki H; Akuta N; Suzuki Y; Suzuki F; Kumada H
    Am J Med; 2006 Nov; 119(11):977-85. PubMed ID: 17071167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
    Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
    J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
    Ikeda K; Arase Y; Kobayashi M; Saitoh S; Someya T; Hosaka T; Suzuki Y; Suzuki F; Tsubota A; Akuta N; Kumada H
    J Gastroenterol; 2003; 38(9):865-76. PubMed ID: 14569444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.